tiprankstipranks
Advertisement
Advertisement

HK:3696 Stock Latest News

Insilico Medicine Strikes Up to $2.5 Billion AI Drug Partnership with SK Biopharmaceuticals
Company AnnouncementsInsilico Medicine Strikes Up to $2.5 Billion AI Drug Partnership with SK Biopharmaceuticals
8d ago
3696
InSilico Medicine Gains Inclusion in Key China Securities Indexes
PremiumCompany Announcements
InSilico Medicine Gains Inclusion in Key China Securities Indexes
15d ago
3696
InSilico Medicine to Join FTSE Global Equity Index Series
PremiumCompany Announcements
InSilico Medicine to Join FTSE Global Equity Index Series
22d ago
3696
InSilico Medicine Wins Strong Shareholder Backing for Board, Auditor and Capital Mandates
PremiumCompany Announcements
InSilico Medicine Wins Strong Shareholder Backing for Board, Auditor and Capital Mandates
28d ago
3696
InSilico Medicine Clarifies Status of Potential Secondary Listing Plans
PremiumCompany Announcements
InSilico Medicine Clarifies Status of Potential Secondary Listing Plans
1M ago
3696
InSilico Medicine to Join Hang Seng Biotech Index in June 2026
PremiumCompany AnnouncementsInSilico Medicine to Join Hang Seng Biotech Index in June 2026
1M ago
3696
InSilico Medicine Deploys USD107 Million into Low-Risk Wealth Products as Cash Pile Grows
Premium
Company Announcements
InSilico Medicine Deploys USD107 Million into Low-Risk Wealth Products as Cash Pile Grows
2M ago
3696
InSilico Medicine Wins China IND Nod for AI-Discovered IPF Drug Rentosertib
Premium
Company Announcements
InSilico Medicine Wins China IND Nod for AI-Discovered IPF Drug Rentosertib
2M ago
3696
InSilico Medicine Sets 2026 AGM to Approve Accounts, Board Mandates and Share Repurchase Authority
PremiumCompany Announcements
InSilico Medicine Sets 2026 AGM to Approve Accounts, Board Mandates and Share Repurchase Authority
2M ago
3696
InSilico Medicine’s UAE Team Advances AI-Designed Brain Cancer Drug to Preclinical Stage
PremiumCompany Announcements
InSilico Medicine’s UAE Team Advances AI-Designed Brain Cancer Drug to Preclinical Stage
2M ago
3696
InSilico Medicine Grants 3.7 Million RSUs to Boost Retention and Performance
PremiumCompany Announcements
InSilico Medicine Grants 3.7 Million RSUs to Boost Retention and Performance
3M ago
3696
InSilico Medicine Strikes Multi-Billion-Dollar AI Drug Discovery Deal With Eli Lilly
PremiumCompany Announcements
InSilico Medicine Strikes Multi-Billion-Dollar AI Drug Discovery Deal With Eli Lilly
3M ago
3696
InSilico Medicine Boosts AI Platform and Advances Clinical Pipeline
PremiumCompany AnnouncementsInSilico Medicine Boosts AI Platform and Advances Clinical Pipeline
3M ago
3696
InSilico Expands AI-Driven CNS Collaboration With Tenacia in USD94.75 Million Deal
Premium
Company Announcements
InSilico Expands AI-Driven CNS Collaboration With Tenacia in USD94.75 Million Deal
3M ago
3696
InSilico Medicine Sets March 27 Board Meeting to Approve 2025 Results
Premium
Company Announcements
InSilico Medicine Sets March 27 Board Meeting to Approve 2025 Results
4M ago
3696
InSilico Medicine Flags Sharper 2025 Loss on Revenue Drop and One-Off Fair Value Hit
PremiumCompany Announcements
InSilico Medicine Flags Sharper 2025 Loss on Revenue Drop and One-Off Fair Value Hit
4M ago
3696
Insilico and TaiGen Hit First Clinical Milestone for AI‑Designed CKD Anemia Drug
PremiumCompany Announcements
Insilico and TaiGen Hit First Clinical Milestone for AI‑Designed CKD Anemia Drug
4M ago
3696
InSilico Medicine to Join Hang Seng Composite Index, Gaining Stock Connect Access
PremiumCompany Announcements
InSilico Medicine to Join Hang Seng Composite Index, Gaining Stock Connect Access
4M ago
3696
InSilico Medicine Strikes AI-Driven Drug Development Pact With CMS
PremiumCompany Announcements
InSilico Medicine Strikes AI-Driven Drug Development Pact With CMS
5M ago
3696
InSilico Medicine Secures HKD39 Million Milestone from Menarini for MEN2501 Trial Progress
PremiumCompany AnnouncementsInSilico Medicine Secures HKD39 Million Milestone from Menarini for MEN2501 Trial Progress
5M ago
3696
InSilico Medicine Strikes HKD931 Million AI-Driven Cardiometabolic Drug Pact with Qilu Pharmaceutical
Premium
Company Announcements
InSilico Medicine Strikes HKD931 Million AI-Driven Cardiometabolic Drug Pact with Qilu Pharmaceutical
5M ago
3696
InSilico Medicine Wins FDA IND Clearance for AI-Designed NLRP3 Inhibitor ISM8969
Premium
Company Announcements
InSilico Medicine Wins FDA IND Clearance for AI-Designed NLRP3 Inhibitor ISM8969
5M ago
3696

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >